Cat Cancer Genetics: New Insights from Study Mirror Human Disease

Cancer is a leading cause of death in domestic cats, a reality many pet owners may not consider. Surprisingly, until recently, the genetic underpinnings of feline cancer have remained largely unexplored. Now, a large-scale international study is changing that, revealing striking similarities between cancer development in cats and in humans.

Uncovering Genetic Links

Led by the University of Guelph, the groundbreaking research represents the first comprehensive genetic mapping of multiple types of cat cancer. Researchers analysed nearly 500 domestic cats from five countries, examining thirteen different cancer types to identify specific “driver genes” responsible for initiating cancer. A significant finding was the overlap of these genes with those found in both humans, and dogs.

Did You Know? The study analysed DNA sequences from tissues already collected by veterinarians, paving the way for collaborative research.

One key example is the FBXW7 gene, the most common driver gene identified in feline breast cancer. In humans, alterations in the same gene are linked to poorer prognoses across various cancers, including breast cancer. Another frequently observed gene, PIK3CA, is already the target of specific treatments in human cancer patients. Similar genetic parallels were found in blood cancers like leukemia and lymphoma, as well as tumors affecting bones, lungs, skin, the digestive system, and the central nervous system.

Shared Environmental Factors

Researchers note that cats are often exposed to similar environmental factors as their owners, such as air pollution and lifestyle-related risks. This suggests that some of the underlying causes of cancer may be shared between species.

Implications for Treatment and Beyond

“This research helps us better understand why cancer develops in cats and people, how our environment influences risk, and potentially how You can better prevent and treat cancer,” stated Dr. Geoffrey Wood, a co-author of the study. The team also discovered that certain chemotherapies are more effective in treating feline breast cancers with a specific FBXW7 mutation than those without it. While this finding is currently based on tissue sample analysis and requires further investigation, it could lead to new treatment strategies for cats and potentially other animals.

Expert Insight: The identification of shared genetic drivers in feline and human cancers underscores the potential for a “One Medicine” approach, where knowledge and therapies are exchanged between veterinary and human medical fields.

The study’s findings, while preliminary, mark a significant advancement. Dr. Louise van der Weyden of the Wellcome Sanger Institute described the research as “one of the biggest developments ever in cat cancer research,” stating that “the genetics of cat tumors is no longer a black box.” This opens the door to precision oncology for cats, and may benefit human cancer treatment as well.

Frequently Asked Questions

What types of cancer were studied?

The researchers investigated thirteen different types of cat cancer, including those affecting the breast, blood, bones, lungs, skin, digestive system, and central nervous system.

What is a “driver gene”?

Driver genes are specific genes that are identified as causing cancer. The study pinpointed these genes in cats and found many are also present in humans and dogs.

Could this research lead to new treatments for humans?

While further research is needed, the identification of shared genetic factors suggests that insights gained from studying feline cancer could potentially inform the development of new therapies for humans.

As research continues, will a deeper understanding of feline cancer genetics translate into improved outcomes for both our animal companions and ourselves?